Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_assertion type Assertion NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_head.
- NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_assertion description "[Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_provenance.
- NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_assertion evidence source_evidence_curated NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_provenance.
- NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_assertion SIO_000772 10064001 NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_provenance.
- NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_assertion wasDerivedFrom ctd_human-2016 NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_provenance.
- NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_assertion wasGeneratedBy ECO_0000218 NP10243.RAaCdgFKfgI-56vgmUOXM0k4Dzxbn3dsydma9yi_gZu_Q130_provenance.